Racial Disparity in Glucagon-Like Peptide 1 and Inflammation Markers Among Severely Obese Adolescents

Diabetes Care - United States
doi 10.2337/dc07-1525
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Glucagon-Like Peptide-1 and Satiety

Nature
Multidisciplinary
1997English

Effect of Glucagon Like Peptide 1| (GLP1) Analogues on Obese Egyptians With and Without Diabetes

The Medical Journal of Cairo University
2019English

Equine Glucagon-Like Peptide-1 Receptor Physiology

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2018English

Effects of Gastric Inhibitory Polypeptide, Glucagon-Like Peptide-1 and Glucagon-Like Peptide-1 Receptor Agonists on Bone Cell Metabolism

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Cardiovascular and Hemodynamic Effects of Glucagon-Like Peptide-1

Reviews in Endocrine and Metabolic Disorders
EndocrinologyMetabolismDiabetes
2014English

Glucose-Sensing in Glucagon-Like Peptide-1-Secreting Cells

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2002English

Modulation of Kv1.3 by the Gut Peptide Glucagon-Like Peptide 1

Biophysical Journal
Biophysics
2019English

Glucagon-Like Peptide-1 Receptor (GLP1R; GLP-1R)

Science-Business eXchange
2009English

Glucagon-Like Peptide 1 Regulates Adipogenesis in 3t3-L1 Preadipocytes

International Journal of Molecular Medicine
MedicineGenetics
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy